首页> 外文期刊>European Journal of Haematology >Non-myeloablative hematopoietic stem cell transplantation in the treatment of severe idiopathic CD4+ lymphocytopenia.
【24h】

Non-myeloablative hematopoietic stem cell transplantation in the treatment of severe idiopathic CD4+ lymphocytopenia.

机译:非清髓性造血干细胞移植治疗严重的特发性CD4 +淋巴细胞减少症。

获取原文
获取原文并翻译 | 示例
           

摘要

A 40-year-old man with severe chronic idiopathic CD4+ lymphocytopenia complicated with opportunistic infections was successfully treated with non-myeloablative allogeneic hematopoietic stem cell transplantation. After conditioning with fludarabine plus low dose of total-body irradiation, CD34+ peripheral blood stem cells obtained by leukapheresis from his HLA-identical sister were infused. T cell and myeloid complete chimerism was achieved at day +28 and remained stable during the follow-up period. The patient did not develop infectious complications during the procedure. At 35 months of follow-up, his CD4+ T cell count was 1019 cells per microliter. Non-myeloablative allogeneic hematopoietic stem cell transplantation should be considered a treatment option for patients with severe forms of idiopathic CD4+ lymphocytopenia.
机译:一名患有重度慢性特发性CD4 +淋巴细胞减少症并伴有机会性感染的40岁男子已成功通过非清髓性同种异体造血干细胞移植治疗。用氟达拉滨加低剂量的全身照射进行调理后,通过白细胞分离术从他的HLA相同的姐妹那里获得了CD34 +外周血干细胞。 T细胞和骨髓完全嵌合是在+28天达到的,并在随访期间保持稳定。患者在手术过程中未发生感染并发症。在35个月的随访中,他的CD4 + T细胞计数为1019细胞/微升。对于患有严重形式的特发性CD4 +淋巴细胞减少症的患者,应考虑非清髓性异基因造血干细胞移植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号